Plain-language summary
Mice receiving the chemotherapeutic cisplatin — a reliable cause of acute kidney injury — were co-treated with carnosine. Kidney function markers were preserved and histological damage was attenuated, raising the possibility of carnosine as a renal adjunct in oncology.
Key takeaways
- ›Renal function markers were preserved.
- ›Histological damage was reduced.
- ›Suggests an adjunct role in chemotherapy regimens.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.